Hepatitis C virus genotype distribution and viral load levels in human immunodeficiency virus co-infected patients;Distribución de los genotipos y niveles de carga viral del virus de hepatitis C en pacientes coinfectados con el virus de inmunodeficiencia humana

Acta Gastroenterologica Latinoamericana

Volumn 38 M4D, Issue 4, 2008, Pages 307-308

  Bolcic, Federico ^a,b   Laufer, Natalia ^a   Quarleri, Jorge ^a,b  

^a Universidad de Buenos Aires   (Argentina)

^b Consejo Nacional de Investigaciones Científicas Y Técnicas ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; VIRUS DNA;

DNA DETERMINATION; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; LIVER TOXICITY; MIXED INFECTION; NONHUMAN; POPULATION DISTRIBUTION; RISK REDUCTION; VIRUS LOAD; AIDS RELATED COMPLEX; GENETICS; HEPATITIS C VIRUS; VIROLOGY; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; MORBIDITY; MORTALITY; PREVALENCE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; VIRAL LOAD;

EID: 58149171775     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Rosenthal E, Poiree M, Pradier C, et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003;17:1803-1809. (Pubitemid 37000098)
2. Murphy EL, Collier AC, Kalish LA, et al. Viral Activation Transfusion Study Investigators, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26.
3. Laufer NL, Quarleri JF, Bouzas MB, Perez HM, Salomon H, Cahn PE. HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges. Medicina 2007;67:82-91.
4. Alberti A, Clumeck N, Collins S, et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005;42:615-624. (Pubitemid 40501675)
5. Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: implications for immune control and therapy. World J Gastroenterol 2007;13:4808-4817. (Pubitemid 47496745)
6. Quarleri JF, Bolcic FM, Bouzas MB, et al. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors. Acta Gastroenterol Latinoam 2007;37:76-83.